Vaccines, blood, antisera, toxins and cultures in   Iceland

Exports In 2023, Iceland exported $78.8M in Vaccines, blood, antisera, toxins and cultures, making it the 44th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 14th most exported product in Iceland. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Iceland are: Germany ($19.5M), Switzerland ($17.5M), United Kingdom ($14.3M), Italy ($12.3M), and Canada ($11.7M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Iceland between 2022 and 2023 were Germany ($13.3M), Italy ($12.1M), and Switzerland ($6.91M).

Imports In 2023, Iceland imported $19.8M in Vaccines, blood, antisera, toxins and cultures, becoming the 138th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 91st most imported product in Iceland. Iceland imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($3.85M), Ireland ($2.73M), Denmark ($2.58M), Italy ($1.91M), and United Kingdom ($1.72M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Iceland between 2022 and 2023 were Italy ($1.4M), Ireland ($1.08M), and Denmark ($827k).